首页|2018-2021年杭州市健康人群白喉IgG抗体水平调查

2018-2021年杭州市健康人群白喉IgG抗体水平调查

扫码查看
目的 评估杭州市健康人群白喉抗体水平.方法 采用分层抽样方法于2018-2021年选择杭州市4个区健康人群采集血清标本,采用酶联免疫吸附试验检测白喉IgG抗体,分析抗体阳性率和几何平均浓度(Geometric mean concentration,GMC).结果 调查对象白喉 IgG 抗体总阳性率为 79.74%(1 086/1 362),GMC 为 0.49IU/mL.0-2 月龄、3-11月龄、1-2岁、3-5岁、6-12岁、13-19岁、20-39岁、≥40岁人群抗体阳性率分别为77.36%、93.18%、97.16%、95.02%、92.65%、61.38%、67.46%、42.37%;GMC 分别为 0.33、0.65、0.70、0.67、0.72、0.28、0.22、0.15IU/mL.多因素分析显示,年龄、地区、含白喉成分疫苗(Diphtheria-containing vaccines,DCV)接种史和接种后时间是抗体阳性率和GMC的影响因素.结论 杭州市健康人群白喉抗体水平总体较高,但随着年龄增长或DCV接种后时间延长而下降.需探讨青少年和成人白喉免疫策略.
Diphtheria IgG antibody levels among a healthy population in Hangzhou city in 2018-2021
Objective To evaluate diphtheria antibody levels in a healthy population in Hangzhou city.Methods We used a stratified sampling method to recruit healthy people in 4 districts of Hangzhou during 2018-2021 and obtained serum samples from subjects.We tested sera for diphtheria IgG antibody using enzyme-linked immunosorbent assay to determine positivity rates and geometric mean concentrations(GMC).Results The overall positivity rate of diphtheria IgG antibody was 79.74%(1 086/1 362),and the GMC was 0.49 IU/mL.Positivity rates for 0-2-month-olds,3-11-month-olds,1-2-year-olds,3-5-year-olds,6-12-year-olds,13-19-year-olds,20-39-year-olds,and ≥40-year-olds were 77.36%,93.18%,97.16%,95.02%,92.65%,61.38%,67.46%,and 42.37%;respective GMCs were 0.33,0.65,0.70,0.67,0.72,0.28,0.22,and 0.15IU/mL.Multivariate analyses showed that age,region,diphtheria vaccination history,and time since vaccination were factors influencing positivity rate and GMC.Conclusions The diphtheria IgG antibody level was high among healthy people in Hangzhou but decreased with increasing age and time since diphtheria vaccination.We need to explore diphtheria immunization strategies for adolescents and adults.

DiphtheriaIgG antibodyHealthy population

许玉洋、刘艳、杜渐、郑伟、张学潮、张小平、陈俊、张晓峰、金俊杰、季冬英

展开 >

杭州市疾病预防控制中心,浙江杭州 310021

上城区疾病预防控制中心,浙江杭州 310004

临安区疾病预防控制中心,浙江杭州 311300

富阳区疾病预防控制中心,浙江杭州 311400

余杭区疾病预防控制中心,浙江杭州 311100

展开 >

白喉 IgG抗体 健康人群

浙江省基础公益研究计划

LGF22H260013

2024

中国疫苗和免疫
中国疾病预防控制中心

中国疫苗和免疫

CSTPCD北大核心
影响因子:2.311
ISSN:1006-916X
年,卷(期):2024.30(1)
  • 26